National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

cetuximab (seh-TUK-sih-mab)

 A monoclonal antibody used to treat certain types of head and neck cancer, and colorectal cancer that has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. Cetuximab binds to the epidermal growth factor receptor (EGFR), which is found on the surface of some types of cancer cells. Also called Erbitux.



Previous Definitions:cervical squamous intraepithelial neoplasia 1, cervical squamous intraepithelial neoplasia 2, cervicectomy, CerviPrep, cervix
Next Definitions:cevimeline, CGP 48664, Chamberlain procedure, chamomile, Chantix

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov